NDSS SUBSIDY - 2022

Continuous glucose monitoring (CGM) now subsidised through NDSS

From 1st July, the Australian Government has announced that the Guardian Sensor 3 will be subsidised for all Australians living with Type 1 diabetes.

 

 

 

Medtronic welcomes the commitment made by the Coalition and Labor to enable expanded access to publicly funded Continuous Glucose Monitoring (CGM) for all patients with Type 1 Diabetes in Australia from 1 July 2022.

An extension of the CGM program is an important commitment that recognises the value of this technology in helping all patients with Type 1, and their Health Care Professionals, manage their condition. It addresses an access gap to this technology, and ensures those who are eligible under the existing CGM program do not have to revert to finger- pricking.

This announcement is a result of the many voices that advocate for Type 1 patients especially the Juvenile Diabetes Research Foundation, Diabetes Australia and the Australian Diabetes Society. Medtronic Australasia will work with Government to support the implementation of this important measure.

How to access subsidised CGM

CGM Initiative eligibility expansion

Access to subsidised continuous glucose monitoring (CGM) and flash glucose monitoring (Flash GM) products through the NDSS is expanding to include all people with type 1 diabetes. This means people with type 1 diabetes aged 21 years or older who do not have concessional status will have access to subsidised CGM and Flash GM products through the NDSS. Rollout of the expansion will commence on 1 July 2022. From this date, all people with type 1 diabetes will be able to apply for access.

Newly eligible people with type 1 diabetes

As a customer of Medtronic you may qualify for a streamlined access process. To access subsidised products through the NDSS, you would normally be required to see your diabetes health professional and have them complete a form. This streamlined pathway is being offered by Diabetes Australia and the NDSS to make the process quicker and easier for you, and potentially enable your access to subsidised CGM or Flash GM products sooner.

You will need to have accessed products directly from Medtronic between 1 January 2022 and 1 June 2022 and be continuing to use the same device.

  1. Go to ndss.com.au/cgm-expansion-form/
  2. Validate your NDSS registration details using your last name and NDSS number
  3. Complete the online form to confirm your contact details and the CGM or Flash GM device you are currently using
  4. Consent to the information you have provided being validated with Medtronic and this validation being shared with the NDSS.

The information you provide will be provided to Medtronic for us to validate. If we can validate your information, we will inform the NDSS and your access to subsidised products for that device will be automatically enabled and you will receive notification.

This pathway will be open on 1 July 2022 (i.e., the online form will be available from 1 July), with access to subsidised CGM or Flash GM products possible from mid-July 2022.

  • If you submit your information to the NDSS between 1 July 2022 and 4 July 2022, and it is successfully validated with Medtronic, your access to subsidised products will commence on 11 July 2022.
  • If you submit your information to the NDSS between 5 July 2022 and 31 July 2022, and it is successfully validated with Medtronic, your access to subsidised products will commence on 8 August 2022.

If your information cannot be validated, you will need to see your diabetes health professional and they will need to complete a Continuous and Flash Glucose Monitoring Access Form.

Not sure about your current CGM technology? Use this table to find out.

If you have not accessed products directly from Medtronic between 1 January 2022 and 1 June 2022 you will need to see your diabetes health professional and have them complete a Continuous and Flash Glucose Monitoring Access Form. This is to nominate the device you will be using and so you can receive training and guidance for use.

Support from your diabetes health professional

Even if you are not required to see your diabetes health professional to have them complete a form, it is important to maintain regular engagement with your diabetes health professional for optimal diabetes management and up-to-date training and education on the use of diabetes technology. Your diabetes health professional is an expert on diabetes care and will help you get the most benefit from your diabetes technology. You should discuss your ongoing use of CGM or Flash GM technology at your next regular appointment.

How to find out more?

Go to the NDSS website to find out more about the eligibility expansion and accessing subsidised CGM and Flash GM products through the NDSS. If you have additional questions, call the NDSS Helpline on 1800 637 700.

If a person has not accessed CGM or Flash GM products directly from a supplier between 1 January 2022 and 1 June 2022 OR they want to use a different device than they are currently/ have previously used, they will need to see their diabetes health professional and have them complete a Continuous and Flash Glucose Monitoring Access Form.

Do you want to learn more?

If you want to know more, please request a call to our team.